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Abstract
Chemokines play a crucial role in immune response and the
development, homeostasis and regulation of the immune
system. They regulate the migration of various types of
leukocytes through interaction with their receptors [1]. The aim
of this work is to inhibit interleukin-8 (IL-8, CXCL8) and
eotaxin (CCL11) to prevent leukocyte migration in
Cell culture models for granulocyte based assays
The human eosinophilic leukemia cell line EoL-1 can be differentiated into
eosinophils with apicidin, and the human myeloid cell line HL-60 can be
differentiated into neutrophils with DMSO and granulocyte colony stimulating
factor (G-CSF).
Both cell lines were cultivated in RPMI medium supplemented with 15 % fetal
bovine serum at 37°C. The EoL-1 cells were induced to differentiate with
100 nM of apicidin at different time points [2] The HL-60 cells were treated
inflammatory diseases. The migration of leukocytes can be
determined with various activity assays and microscopic
methods. The first step in assay development is to find out
which concentration of the chemokines has the strongest
effect. Once assay conditions have been optimized potential
inhibitors can be tested. These inhibitors can be peptides with
a similar amino acid sequence like the CXCL8 and CCL11
receptors but also natural products like naringenin. Before the
i ti f l k t b t di d th ll h t b
.
with 1,25 % dimethylsulfoxid and 25 ng/ml G-CSF for 6 days [3].
Test for differentiation markers
• EoL-1 cells were differentiated 7, 8, and 9 days with 100 nM apicidin.
• Cell lysates were tested for eotaxin receptor CCR3 by Western Blot
• Molecular weight of CCR3: 41 kDa
50 kDa
37 kDam gra on o eu ocy es can e s u e e ce s ave o e
differentiated into neutrophil and eosinophil granulocytes. To
show after how many days differentiation was complete
Western Blot analysis was performed.
Migration Assay
• Idea: Differentiated HL-60 cells migrate upon interaction with interleukin-8 in
direction of the concentration gradient.
CCR3 was expressed in undifferentiated and differentiated cells.
 
undifferentiated EoL-1 cells
7 days 8 days 9 days
differentiated EoL-1 cells
7 days 8 days 9 days
Cell migration of microstructured surfaces
Proteins printed on surfaces in stripes of
increasing thickness or with decreasing spacing
• The assay was established with a transwell system
•Procedure: Differentiated HL-60 cells were suspended medium and a total of
1x 106 cells were added into the upper well of the transwell inserts (membrane
with 3 µm pores). The lower wells were filled with medium containing different
concentrations of IL-8. After an incubation time of 30 min the cells in the upper
and lower wells were counted with the Casy cell counter and the number of
migrated cells calculated.
IL-8 dependent chemotaxis of
differentiated HL 60 cells Initial cell
Microcontact printing (µCP)
• Idea: Microstructured self-assembled monolayers
(SAM) of alkane- or aminothiols on gold surfaces 
• Adsorption of chemokines to alkane chains
• Or: Adsorption of heparin to aminophenolthiol
d f h ki t h i
Gradient patterns of FITC by µCP  
investigated by fluorescence
microscopy (FITC-filter)
Migration of cells due to 2D gradient
are preceived as protein gradients by several
cell types [4]. We are testing different methods
to produce interleukin-8 patterns to study the
response of neutrophils to these patterns.
Conclusions and Outlook
- .
number is expressed as 100 %, and
IL-8 chemotaxis is expressed as a
percentage of the initial cell number.
Positive control: 100 nM fMLP;
Negative control: chemotaxis medium
Optimum chemotaxis response at 10 nM IL-8 after 30 min incubation
an o c emo ne o epar n.  
15
10
5
0
µ
m
151050
µm
-2
0
2
nm
20
15
10
5
0
µm
20151050
µm
-1.0
-0.5
0.0
0.5
1.0
nm
10
8
6
4
2
0
µ
m
1086420
µm
-10
-5
0
5
10
nm
1.5nm
1.0
0.5
0.0
-0.5
-1.0
H
e
ig
h
t
43210
µm
1.5nm
1.0
0.5
0.0
-0.5
-1.0
H
e
ig
h
t
6543210
µm
10nm
5
0
-5
-10
H
ei
gh
t
86420
µm
Hight difference 
measured by
AFM 2.4 nm
Hight difference 
measured by
AFM 2.2 nm
Inverse hight 
difference 
By AFM 16.4 nm
References
[1] A. Zlotnik and O. Yoshie, Immunity 2000, 12, 121-127.
[2] K. Ishihara et al,  Life Science 2007, 80, 1213-1220.
[3] T. Yamaguchi, et al., Arch. Biochem. Biophys. 1998, 353, 93-100.
[4] A. C. von Philipsborn, Development 2006, 133, 2487-2495.
  
•CCR3 can´t be used as a differentiation marker for EoL-1 cells.
•Proteoglycan2, Peroxidasin and CD11b will be tested as       potential 
differentiation marker for EoL-1 cells.
•IL-8 shows the strongest effect on the migration of HL-60 at a 
concentration of 10 nM.
•Potential inhibitors for IL-8 will be tested in the migration assay.
•Recombinant IL-8 will be analyzed in several activity assays.
• AFM data shows the selective binding of heparin to amino-
terminated thiols.
• Procedure: A PDMS stamp with a lateral pattern was loaded with a solution
of octadecanethiol. The thiol pattern was printed on a gold coated silicon
wafer. The silicon wafer was incubated with aminophenolthiol and then with
heparin for 1 hour. Hight profiles of the surface were measured after every
incubation step to control surface topography.
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•The binding of IL-8 to heparin will be also investigated by AFM. 
•The migration of leukocytes on microstructured surfaces will be 
characterized.
. 
